Neurology News

The FDA has cleared an investigational new drug application for an alpha-kinase 1 inhibitor for clinical evaluation in those with retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis and headache, or ROSAH, syndrome.

DENVER — Early initiation of treatment with ofatumumab showed sustained benefit to those with treatment-naïve relapsing multiple sclerosis, Gabriel Pardo, MD, said in this Healio video from the American Academy of Neurology annual meeting.

Neuromuscular exercise and pain neuroscience education did not yield superior outcomes to education alone, however, interventions may improve clinical, pain and functional outcomes after total knee arthroplasty, according to published data.

According to statistics reported in a recent release from Sutter Health, up to 15% of strokes are suffered by individuals aged younger than 45 years, with incidence rising.

Stroke prevalence increased more than 15% among Americans aged 65 years and younger in the last decade, research published in MMWR showed.

Patients with idiopathic infantile nystagmus syndrome had better best-corrected visual acuity but scored lower on quality-of-life assessments compared with those whose condition was associated with ocular disease, according to research.

Use of polarization-sensitive OCT to identify scleral fiber patterns in highly myopic eyes may help develop targeted therapies for scleral abnormalities and mitigate damage to surrounding neural tissue, according to research.

NEW YORK — New data suggests a link between inflammation during pregnancy and postpartum anxiety among women experiencing the highest anxiety symptoms, according to a poster at the American Psychiatric Association annual meeting.

The Foundation for the NIH has announced the launch of a public-private partnership to advance knowledge of and accelerate drug development for individuals affected by amyotrophic lateral sclerosis.

As healers, we are most comfortable and confident when we can rely on the long-established armamentarium of countless medications created by the American pharmaceutical industry.